A team of researchers from five Swedish universities have made a remarkable breakthrough in the treatment of cancer, with an equally innovative source of funding.
Led by Karolinska Institutet and the Science for Life Laboratory in Stockholm, the team has made inhibitors that kill cancer cells but not normal cells.
“We are first to show this new way of targeting cancer and this is likely going to be the major path for drug development in the future,” said Thomas Helleday, holder of the Söderberg Professorship at Karolinska Institutet, who heads the study.
Until now, most modern anti-cancer drugs have been tailored to target the genetic makeup of the cancer – a so-called personalized treatment. Sometimes this can have a long-lasting effect, but more often than not the cancers mutate to become resistant. What the team has managed to do is to target an enzyme that is required for all cancer cells for survival, but that normal cells do not need.
Helleday explained that the treatment – which comes in the form of a pill – can kill any cancer and does not have any severe side effects.
“Some say our finding sounds too good to be true, and I understand their gut feeling after seeing so many promising cancer treatments fail,” he said. “My research group has made paradigm shifts before and to those skeptics I say: just sit back and enjoy the revolution!”
What’s also revolutionary is the way the research is financed, through “open innovation” and “crowd sourcing”.
“I started a public foundation that owns all intellectual property and the idea is that we manufacture large amounts of the drug and provide it for free to the worldwide academic community, so they can design their own clinical trials and run them”, Helleday said.
“Also, as there is a public foundation behind the drug, it will not be used to enrich a few individuals, but be used for further work on new medicines.”
A lot of work remains to be done before it is time for clinical trials, which are still a year or two away, Helleday said.
Being based in Stockholm brings many advantages, including a number of highly trained drug developers looking for new challenges, he said.
“A major point is that Swedish Universities do not claim or take control on intellectual property, allowing us to donate it to a public foundation,” Helleday said.
“Another advantage is the collaborative nature of Swedes. We collaborated with five different universities to progress the project, which would have been difficult elsewhere.”
Their concept is presented in two articles in science journal Nature, with the aim of spreading the word to as many as possible in the research community.
“It has generated interest from academics across the world, to try the new concept on the cancer indication they have specialized in,” Helleday said.
The team has also sent out the compound to hundreds of scientists across the globe in an effort to increase the speed of innovation and to reach the goal of curing cancer more quickly. By freely sending out compounds, they have increased competition.
 “Hundreds of scientists are advancing more quickly than one and we increase the chances of overall success,” Helleday said.
The Latest on: Cancer breakthrough
via Google News
The Latest on: Cancer breakthrough
- Scientists at Tel Aviv U. announce 'Breakthrough' in cancer treatmenton August 4, 2022 at 12:37 pm
Researchers have identified a molecule that promises to be more effective than an antibody currently used to treat the disease.
- Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detectionon August 4, 2022 at 7:11 am
Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect ™ test for oral & throat cancer, the first to launch in a series of diagnostic tests in ...
- Across the U.S., Cancer Survivors, Caregivers, and their Loved Ones will Climb for a Cureon August 3, 2022 at 7:46 am
On August 6 and 7, Fight Colorectal Cancer (Fight CRC), a national nonprofit organization, and advocates from across the country will be hosting and participating in climbing events to raise awareness ...
- Breakthrough in prostate cancer researchon August 3, 2022 at 6:54 am
Researchers from the CHUM Research Centre and the Polytechnique Montreal have discovered a new technique to detect an aggressive form of prostate cancer.
- AnHeart Therapeutics Receives FDA Breakthrough Therapy Designation for Taletrectinib in ROS1-Positive Non-Small Cell Lung Canceron August 3, 2022 at 5:00 am
AnHeart Therapeutics Receives FDA Breakthrough Therapy Designation for Taletrectinib in ROS1-Positive Non-Small Cell Lung Cancer ...
- Breakthrough Discovery: AccuTOX(TM) Effectively Kills Cancer Cells by Directly Eliciting DNA Damageon August 2, 2022 at 12:15 am
Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug ...
- What Is Breakthrough Bleeding and Why Exactly Does It Happen?on August 1, 2022 at 9:00 am
Breakthrough bleeding is any type of bleeding between periods. It can range from a few drops of blood that fill up your entire pad or tampon. People with female reproductive organs can experience ...
- Man cured of HIV, cancer following breakthrough stem cell transplant: Doctorson July 28, 2022 at 4:05 pm
A 66-year-old man who was diagnosed with HIV in 1988 is said to be free of both the HIV virus and cancer, following a stem cell transplant from an unrelated donor for leukemia, according to a ...
- Breakthrough cancer treatment uses DNA defects to fight drug-resistant tumorson July 28, 2022 at 11:14 am
A new drug uses DNA repair defects to target drug-resistant tumors, such as the most aggressive type of brain cancer, Glioblastoma.
- Medical Moment: A breakthrough cancer treatment for dogson July 27, 2022 at 2:38 pm
Dogs get cancer at roughly the same rate as humans, while there is less information about the rate of cancer in cats. Some cancers, such as lymphoma, are more common in cats than in dogs.
via Bing News